EQUITY RESEARCH MEMO

Tecomet

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

Tecomet is a leading contract manufacturer of high-precision metal components and assemblies, primarily serving the medical device and aerospace & defense industries. Founded in 1964 and headquartered in Wilmington, Massachusetts, the company offers end-to-end services from design and prototyping to full-scale production. It is recognized as the largest contract manufacturer to the orthopedics industry, producing implants and surgical instruments, and operates a global network of facilities. As a private company, Tecomet does not disclose financials, but its market position is supported by trends in aging populations, rising orthopedic procedures, and increased defense spending. The company faces competition from other contract manufacturers but benefits from long-term relationships with major medical device OEMs. Key challenges include supply chain volatility and regulatory changes. Overall, Tecomet is well-positioned in niche, high-barrier markets.

Upcoming Catalysts (preview)

  • Q3 2026Orthopedic Implant Demand Recovery75% success
  • Q4 2026Aerospace & Defense Contract Wins60% success
  • Q2 2027Capacity Expansion in Key Markets50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)